What are Zevra Therapeutics, Inc.'s profit margins?

Zevra Therapeutics, Inc. (ZVRA) runs a 86.1% gross margin and a -103.9% operating margin, with a 101.6% net margin.

Where do Zevra Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Zevra Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Zevra Therapeutics, Inc. ZVRA Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	86.1%+7.2pp	84.5%+15.9pp	80.7%+13.5pp	72%-3.2pp	78.8%-10.3pp
Net margin	101.6%+328pp	78.2%+525pp	41.9%+408pp	4.3%+286pp	-226.6%-48.2pp
Returns
Return on equity	100.7%+305pp	85.7%+294pp	34.8%+171pp	3.5%+150pp	-204.8%-113pp
Return on invested capital	-0.1%+185pp	-49.9%+141pp	-53.2%+120pp	-64.6%—	-184.7%+166pp
Efficiency
Asset turnover	0.5×+0.3×	0.5×+0.3×	0.4×+0.2×	0.3×+0.1×	0.3×0.0×
Liquidity
Current ratio	4.9×+1.9×	5.7×+3.2×	8.6×+5.7×	7.9×+5.9×	3×+0.9×
Leverage
Debt-to-equity	0×-1.5×	0.4×-1.1×	0.5×-0.4×	0.5×-1.3×	1.5×+1.4×
Net debt / EBITDA	-35.8×—	——	——	——	——
Per Share
Book value per share	$3.42+351%	$2.70+215%	$2.38+63.1%	$2.08+169%	$0.76—
Valuation
Market capitalization	$773.23M+56.4%	$504.43M+13.3%	$533.84M+83.6%	$500.32M+144%	$405.33M+84.4%
Price / earnings	6.2×—	6.1×—	15.1×—	189.2×—	——
Price / sales	6.3×-5.9×	4.7×-14.1×	6.3×-5.5×	8.1×-0.6×	10×+2.1×
Price / book	3.8×-8.3×	3.3×-8.0×	4×-0.2×	4.3×-2.0×	9.9×+5.4×
EV / EBITDA	257.4×—	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Zevra Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Zevra Therapeutics, Inc.'s profit margins?: Zevra Therapeutics, Inc. (ZVRA) runs a 86.1% gross margin and a -103.9% operating margin, with a 101.6% net margin.
Where do Zevra Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Zevra Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.